Docking simulation is important in the process of drug design, mainly used for the prediction of interactions receptor(protein)-substrate. This study aims to understand the interaction between Chromium(III) nicotinate [Cr(O-nic) 
INTRODUCTION
Diabetes is one disease that can lead to death, known as the "silent killer". The number of people with diabetes increased from year to year, based on data estimated the prevalence of Diabetes Mellitus number of diabetics in the world reached 285 million in 2010 and expected to rise to 439 million by 2030. People with diabetes in Indonesia reached 7 million in 2010 and is predicted to rising to 20 million in 2030 (Shaw et al., 2010) .
Along with cases of diabetes are increasing rapidly, many researchers are working to find new supplements as an alternative for diabetics, especially for diabetes type 2. As had been widely developed additional food supplements containing chromium compounds, especially Cr(III), which is believed to be a substance to treat type 2 diabetes (Cefalu and Hu, 2004) .
The chromium(III) nicotinate is known as the antidiabetic supplement based on studies Schwarz and Mertz (1959) , the isolation of yeasts and obtain compounds containing chromium(III), nicotinic acid, glutamic acid, glycine and cysteine are known as Glucose Tolerance Factor (GTF). The GTF can stimulate insulin so that it can lower glucose levels in the blood. Subsequent studies reported the isolation of GTF from brewer's yeast and reports that contain GTF chromium (III), nicotinic acid, glutamic acid, glycine and cysteine (Toepfer, 1977) .Yeast isolation results conducted by Barrett, report the form of chromium(III) nicotinate is octahedral with two nicotinic ligands that are connected through the N atoms of pyridine with trans position, four other ligands are chloride. The same results reported by Mertz, states that the structure of the chromium(III) nicotinate is octahedral have two nicotinic acids with the N atom of pyridine bound to Cr, the other two bidentate ligands is the donor of the amino acid glycine and cysteine. Chromium(III) nicotinate is predicted to interact with a Protein Tyrosine Phosphatase (PTP) which is the insulin receptor to activate the insulin, similary with vanadat (Thompson et al., 2009) . After active insulin sendS a signal to transport glucose to enter glucose from outside the cell to inside the cell, so that the levels of glucose in the blood falls. Although chromium(III) nicotinic has been widely marketed as an antidiabetic supplement, but its single crystal structure has so far not been obtained. Chromium (III) nicotinate used as a supplement in the form of a polymer.
Until now no one has experimentally succeeded in isolating the active center PTP interacting with chromium(III) nicotinate of complex compounds. Therefore, in this research, molecular modeling the interaction between of chromium(III) nicotinate of complex compounds with the active site PTP using docking methods and ONIOM. Calculations using a docking method to determine the active site of PTP interacting with chromium complex. Furthermore, the calculation is continued using the hybrid method ONIOM that include various levels of theory in its calculations but applied to atoms of different subunits in the molecule. The advantages of this method is in addition to calculating the interaction the active site of PTP with chromium(III) nicotinate complex compounds, and can know the atomic type of amino acid interacted with Cr(III) nicotinate.
The purpose of this research is studying the interaction of complex compounds of Cr(III) nicotinate with a protein tyrosine phosphatase (PTP) computationally. The results of this study were used to understand the molecular mechanisms of complex compounds of Cr(III) nicotinate as an antidiabetic.
MATERIALS AND METHODS
This research is consists of three stages: i) The determining thermodynamic stability, which conducted a study of computing the structures of complex compounds of Cr(III) nicotinate with various models of structures. This phase is carried out to obtain the four structures of complex compounds are the most thermodynamically stable.ii) Stage docking, which conducted a study of the interaction of complex compounds of Cr(III) nicotinate with PTP with docking method. The results of this study aim to identify the types of amino acids in the PTP interacting with complex compounds Cr(III) nicotinate, iii) Phase ONIOM calculation, namely to study the interaction of complex compounds of Cr(III) nicotinate with PTP with ONIOM method. This stage aims to determine the types of atoms of amino acids that interact with the Cr(III) nicotinate complex.
The theory used was density functional theory (DFT) with B3LYP theory level at basis set 6-31G(d). The entire computational calculations performed in this study use the Gaussian 09 software version December 2012 and computer HPC ITB with 20 nodes and each nodes consisting of 24 Intel processor cores 16 GB with Rock Cluster system. The results of computational calculations were visualizedby software Chemcraft, Jmol, and Avogadro. All calculation in this study does not involve solvents, all simulations performed in a gaseous stated.
The stability thermodynamic of Cr(III)-nic complexes was determined by Energy and Enthalpyvalues. The formation energy total of complexes (∆E) was determined by calculating the difference between the energy of the complex to the center atomic energy with ligands in a separate state (Cramer, 2004) . The negative values of energy and formation enthalpy indicate that the compounds are thermodynamically stable, the two energy parameters are defined in equations (1) (Toepfer, 1977) . Model structure of Cr(III) nicotinate made by i) variation of donor atoms N and O, ii) variations in the position of trans and cis, thus will be discussed four models of the structure of the Cr(III) nicotinate which interacts with PTP. Here are the four model of the structure of the chromium (III) nicotinic. Figure 1 Interactions Chromium(III) Nicotinate with PTP The docking methods used to predict drug (substrate) the right to bind to the enzyme (protein) (Smith et al., 2007) . The results docking calculations show that four models of structures interacting with amino acids different. Here is a form of interaction PTP with four models of the structure.The forms of interaction docking calculation results shown in Figure 2 below. In the structure of transCr(N-nic) 2 interaction with the amino acids Leu13, Ser47, Trp49, Asn50 and Tyr131, while the structure interaction cisCr(N-nic) 2 the amino acid Ser47, Trp49, Asn50 and Tyr131. Interactions they both are outside the active site, which differs by only one amino acid in the structure transCr(N-nic) 2 , namely Leu13 which is located on the active side. The calculation result most of the interaction occurs outside the active site of PTP, it can be predicted to model the structure of Cr(N-nic) 2 both trans and cis not be the inhibition of PTP, but has other properties that until now unknown. 
CONCLUSION
The results of computational calculations indicate that the best interaction wit PTP is transCr(O-nic) 2 structure model with the lowest interaction energy is -6.5 kcal/mol. The bond is formed consisting of seven hydrogen bond and a sulfide bond with 2.5Å distance.
